Carlyle Leads Majority Growth Investment in Saama Technologies
October 20, 2021
Global investment firm Carlyle led a strategic growth investment of up to $430 million to acquire a majority stake in Saama Technologies. A syndicate of healthcare-focused investors — including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures and Population Health Partners — will co-invest to accelerate Saama's AI-driven Life Science Analytics Cloud and expand go-to-market and R&D capabilities.
- Buyers
- Carlyle, Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures, Population Health Partners
- Targets
- Saama Technologies
- Industry
- AI & Machine Learning
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.